Immuneering Corp (IMRX)
1.42
-0.06
(-4.05%)
USD |
NASDAQ |
Apr 30, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
Immuneering Total Assets (Quarterly): 102.58M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 102.58M |
| September 30, 2023 | 113.88M |
| June 30, 2023 | 124.90M |
| March 31, 2023 | 107.70M |
| December 31, 2022 | 122.37M |
| September 30, 2022 | 133.69M |
| June 30, 2022 | 142.05M |
| Date | Value |
|---|---|
| March 31, 2022 | 152.45M |
| December 31, 2021 | 166.70M |
| September 30, 2021 | 164.04M |
| June 30, 2021 | 53.04M |
| March 31, 2021 | 32.86M |
| December 31, 2020 | 38.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
32.86M
Minimum
Mar 2021
166.70M
Maximum
Dec 2021
111.90M
Average
122.37M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Geron Corp | 394.08M |
| SELLAS Life Sciences Group Inc | 6.219M |
| Elicio Therapeutics Inc | 27.15M |
| Vistagen Therapeutics Inc | 131.07M |
| ADMA Biologics Inc | 329.18M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.01M |
| Shareholders Equity (Quarterly) | 90.58M |